4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017037
Chief Commercial Officer acquired 35,021 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Yarema Kristin · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 1 in the form | +35,021 | 92,289 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-01 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +52,862 | 52,862 | D |
Loading xslF345X03/doc4.xml…